Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enli Liu

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Blood|November 9, 2016
A subset of virus-specific CD161<sup>+</sup> T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AMLAbdullah Alsuliman, Muharrem Muftuoglu, Ahmad Khoder, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
The New England Journal of Medicine|November 4, 2011
Inducible apoptosis as a safety switch for adoptive cell therapyAntonio Di Stasi, Siok-Keen Tey, Gianpietro Dotti, et al.
Frontiers in Immunology|January 31, 2018
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by LenalidomideHila Shaim, Zeev Estrov, David Harris, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Blood|July 24, 2014
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDAhmad Khoder, Anushruti Sarvaria, Abdullah Alsuliman, et al.
Cell Reports|January 4, 2025
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cellsLuciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, et al.
The New England Journal of Medicine|February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsEnli Liu, David Marin, Pinaki Banerjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Blood|September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyConrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Blood|November 9, 2016
A subset of virus-specific CD161<sup>+</sup> T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AMLAbdullah Alsuliman, Muharrem Muftuoglu, Ahmad Khoder, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
The New England Journal of Medicine|November 4, 2011
Inducible apoptosis as a safety switch for adoptive cell therapyAntonio Di Stasi, Siok-Keen Tey, Gianpietro Dotti, et al.
Frontiers in Immunology|January 31, 2018
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by LenalidomideHila Shaim, Zeev Estrov, David Harris, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Blood|July 24, 2014
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDAhmad Khoder, Anushruti Sarvaria, Abdullah Alsuliman, et al.
Cell Reports|January 4, 2025
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cellsLuciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, et al.
The New England Journal of Medicine|February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsEnli Liu, David Marin, Pinaki Banerjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Blood|September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyConrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
Pageof 7